title: Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients.
abstract: GABAergic inhibition and particularly perisomatic inhibition play a crucial role in controlling the firing properties of large principal cell populations. Furthermore, GABAergic network is a key element in the therapy attempting to reduce epileptic activity. Here, we present a review showing the synaptic changes of perisomatic inhibitory neuronal subtypes in the hippocampus of temporal lobe epileptic patients, including parvalbumin- (PV-) containing and cannabinoid Type 1 (CB1) receptor-expressing (and mainly cholecystokinin-positive) perisomatic inhibitory cells, known to control hippocampal synchronies. We have examined the synaptic input of principal cells in the dentate gyrus and Cornu Ammonis region in human control and epileptic hippocampi. Perisomatic inhibitory terminals establishing symmetric synapses were found to be sprouted in the dentate gyrus. Preservation of perisomatic input was found in the Cornu Ammonis 1 and Cornu Ammonis 2 regions, as long as pyramidal cells are present. Higher density of CB1-immunostained terminals was found in the epileptic hippocampus of sclerotic patients, especially in the dentate gyrus. We concluded that both types of (PV- and GABAergic CB1-containing) perisomatic inhibitory cells are mainly preserved or showed sprouting in epileptic samples. The enhanced perisomatic inhibitory signaling may increase principal cell synchronization and contribute to generation of epileptic seizures and interictal spikes.
authors.affiliation: Institute of Cognitive Neuroscience and Psychology, Research Center of Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
authors.forename: Lucia
authors.initials: L
authors.lastname: Wittner
authors.affiliation: Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
authors.forename: Zsófia
authors.identifier: 0000-0001-5050-6980
authors.initials: Z
authors.lastname: Maglóczky
mesh_terms: D001344:Autopsy; D001369:Axons / Q000378:metabolism; D001931:Brain Mapping; D002766:Cholecystokinin / Q000378:metabolism; D003712:Dendrites / Q000378:metabolism*; D018891:Dentate Gyrus / Q000196:embryology; D004833:Epilepsy, Temporal Lobe / Q000503:physiopathology*; D059330:GABAergic Neurons / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D007150:Immunohistochemistry; D009474:Neurons / Q000378:metabolism; D010320:Parvalbumins / Q000378:metabolism; D017966:Pyramidal Cells / Q000378:metabolism; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism; D018079:Receptors, GABA / Q000378:metabolism; D015398:Signal Transduction; D013569:Synapses / Q000378:metabolism*; D013702:Temporal Lobe / Q000503:physiopathology*
chemical_list: C571130:CNR1 protein, human; D010320:Parvalbumins; D043884:Receptor, Cannabinoid, CB1; D018079:Receptors, GABA; D002766:Cholecystokinin